{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:01:58Z","timestamp":1793505718339,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ajem.2021.08.082","type":"journal-article","created":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T02:51:13Z","timestamp":1636167073000},"page":"248-256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Intravenous diltiazem versus metoprolol for atrial fibrillation with rapid ventricular rate: A meta-analysis"],"prefix":"10.1016","volume":"51","author":[{"given":"Qingsu","family":"Lan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengchao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanhu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxian","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.ajem.2021.08.082_bb0005","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1161\/CIRCULATIONAHA.114.014343","article-title":"Mass screening for untreated atrial fibrillation: the STROKESTOP study","volume":"131","author":"Svennberg","year":"2015","journal-title":"Circulation."},{"issue":"932","key":"10.1016\/j.ajem.2021.08.082_bb0010","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/pmj.79.932.313","article-title":"Emergency management of atrial fibrillation","volume":"79","author":"Wakai","year":"2003","journal-title":"Postgrad Med J"},{"issue":"9989","key":"10.1016\/j.ajem.2021.08.082_bb0015","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0140-6736(14)61774-8","article-title":"50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham heart study: a cohort study","volume":"386","author":"Schnabel","year":"2015","journal-title":"Lancet."},{"issue":"5","key":"10.1016\/j.ajem.2021.08.082_bb0020","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.amjcard.2018.05.015","article-title":"The disease burden of atrial fibrillation in China from a national cross-sectional survey","volume":"122","author":"Wang","year":"2018","journal-title":"Am J Cardiol"},{"issue":"19","key":"10.1016\/j.ajem.2021.08.082_bb0025","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.ehj.2004.06.030","article-title":"Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian stroke registry","volume":"25","author":"Steger","year":"2004","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.ajem.2021.08.082_bb0030","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.ajem.2018.01.066","article-title":"Emergency medicine considerations in atrial fibrillation","volume":"36","author":"Long","year":"2018","journal-title":"Am J Emerg Med"},{"issue":"21","key":"10.1016\/j.ajem.2021.08.082_bb0035","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"38","key":"10.1016\/j.ajem.2021.08.082_bb0040","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ajem.2021.08.082_bb0045","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jemermed.2015.01.014","article-title":"Diltiazem vs. metoprolol in the Management of Atrial Fibrillation or flutter with rapid ventricular rate in the emergency department","volume":"49","author":"Fromm","year":"2015","journal-title":"J Emerg Med"},{"key":"10.1016\/j.ajem.2021.08.082_bb0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajem.2020.11.073","article-title":"Comparison of sustained rate control in atrial fibrillation with rapid ventricular rate: metoprolol vs. Diltiazem","volume":"40","author":"Hargrove","year":"2021","journal-title":"Am J Emerg Med"},{"issue":"6","key":"10.1016\/j.ajem.2021.08.082_bb0055","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/emj.2003.012047","article-title":"Comparison of the effectiveness of intravenous diltiazem and metoprolol in the management of rapid ventricular rate in atrial fibrillation","volume":"22","author":"Demircan","year":"2005","journal-title":"Emerg Med J"},{"issue":"24","key":"10.1016\/j.ajem.2021.08.082_bb0060","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.2146\/ajhp160126","article-title":"Diltiazem versus metoprolol for rate control in atrial fibrillation with rapid ventricular response in the emergency department","volume":"73","author":"Hines","year":"2016","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ajem.2021.08.082_bb0065","article-title":"Evaluation of the blood pressure effects of diltiazem versus metoprolol in the acute treatment of atrial fibrillation with rapid ventricular rate","author":"Nu\u00f1ez Cruz","year":"2020","journal-title":"Am J Emerg Med"},{"issue":"9","key":"10.1016\/j.ajem.2021.08.082_bb0070","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.ajem.2020.06.034","article-title":"Hemodynamic comparison of intravenous push diltiazem versus metoprolol for atrial fibrillation rate control","volume":"38","author":"Nicholson","year":"2020","journal-title":"Am J Emerg Med"},{"issue":"1","key":"10.1016\/j.ajem.2021.08.082_bb0075","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ajem.2018.04.062","article-title":"Metoprolol vs. diltiazem in the acute management of atrial fibrillation in patients with heart failure with reduced ejection fraction","volume":"37","author":"Hirschy","year":"2019","journal-title":"Am J Emerg Med"},{"issue":"3","key":"10.1016\/j.ajem.2021.08.082_bb0080","first-page":"224","article-title":"A Compariative study on the efficacy and safety of intravenous diltiazem and metoprolol in elderly heart failure patients with rapid atrial fibrillation","volume":"15","author":"Ye","year":"2007","journal-title":"Chin J Arterioscler"},{"issue":"9","key":"10.1016\/j.ajem.2021.08.082_bb0085","first-page":"4556","article-title":"Efficacy of intravenous diltiazem and metoprolol in the treatment of atrial fibrillation with rapid ventricular rate Chin","volume":"8","author":"Kong","year":"2008","journal-title":"J Misdiagn"},{"issue":"2","key":"10.1016\/j.ajem.2021.08.082_bb0090","first-page":"83","article-title":"Effect of intravenous diltiazem and metoprolol on patients with atrial fibrillation with rapid ventricular rate","volume":"28","author":"Sun","year":"2020","journal-title":"Clin Res"},{"issue":"2","key":"10.1016\/j.ajem.2021.08.082_bb0095","first-page":"206","article-title":"Contrasting the effectiveness of metoprolol and Diltiatem in rapid atrial fibrillation just by intravenous injection","volume":"16","author":"Zhong","year":"2010","journal-title":"Int Med Health Guid News"},{"issue":"1","key":"10.1016\/j.ajem.2021.08.082_bb0100","first-page":"69","article-title":"Therapeutic efficacy of metoprolol and diltiazem on the treatment of rapid atrial fibrillation","volume":"16","author":"Lin","year":"2007","journal-title":"Chin J Cardiovasc Rehabil Med"},{"issue":"1","key":"10.1016\/j.ajem.2021.08.082_bb0105","first-page":"125","article-title":"A study on the efficacy of intravenous diltiazem and metoprolol on in elderly heart failure with rapid atrial fibrillation","volume":"15","author":"Gao","year":"2013","journal-title":"Chin J Med Guide"},{"issue":"10","key":"10.1016\/j.ajem.2021.08.082_bb0110","first-page":"1805","article-title":"Comparison of the effectiveness of intravenous diltiazem and metoprolol in controlling the rapid ventricular rate in patients with atrial fibrillation","volume":"18","author":"Diao","year":"2009","journal-title":"Chin J Emerg Med"},{"issue":"6","key":"10.1016\/j.ajem.2021.08.082_bb0115","first-page":"895","article-title":"Emergency treatment of rapid atrial fibrillation and retrospective analysis of 1 82 cases","volume":"11","author":"Zhang","year":"2009","journal-title":"Chin J Med Guide"},{"issue":"10","key":"10.1016\/j.ajem.2021.08.082_bb0120","first-page":"83","article-title":"The compared of the effect of metoprolol, diltiazem and Cedilanid for rapid atrial fibrillation","volume":"20","author":"Han","year":"2013","journal-title":"China Mod Med"},{"issue":"6","key":"10.1016\/j.ajem.2021.08.082_bb0125","first-page":"136","article-title":"Atrium to shiver 112 example treament observation","volume":"2","author":"Fan","year":"2011","journal-title":"Chin Manipul Qi Gong Ther"},{"key":"10.1016\/j.ajem.2021.08.082_bb0130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med Res Methodol"},{"issue":"5","key":"10.1016\/j.ajem.2021.08.082_bb0140","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2165\/00003495-198529050-00001","article-title":"Diltiazem. A review of its pharmacological properties and therapeutic efficacy","volume":"29","author":"Chaffman","year":"1985","journal-title":"Drugs."},{"issue":"13","key":"10.1016\/j.ajem.2021.08.082_bb0135","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1056\/NEJM197909273011306","article-title":"Drug therapy: metoprolol","volume":"301","author":"Koch-Weser","year":"1979","journal-title":"N Engl J Med"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675721008883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675721008883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:57:30Z","timestamp":1760025450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675721008883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":28,"alternative-id":["S0735675721008883"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2021.08.082","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous diltiazem versus metoprolol for atrial fibrillation with rapid ventricular rate: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2021.08.082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}